Director, Pharmacometrics

The Director, Pharmacometrics will lead quantitative analyses in Oncology, Inflammation, and Virology therapeutic areas throughout all stages of drug development, from first-in-human through Phase IV clinical trials. Responsibilities include conducting, interpreting, and reporting these analyses, supporting regulatory filings, and championing model-informed drug development (MIDD) as a subject matter expert. The role involves evaluating and applying state-of-the-art quantitative pharmacology approaches for clinical pharmacology decision-making and global regulatory submissions, guiding dose regimen/optimization strategies, developing high-quality modeling and simulation strategies and content, and ensuring timely execution of deliverables. Additionally, the Director will present findings to regulators and stakeholders and provide training within and outside the department.